Tweet
Cell Rep
. 2024 Feb 29;43(3):113891.
doi: 10.1016/j.celrep.2024.113891. Online ahead of print. SARS-CoV-2 targets ribosomal RNA biogenesis
V Talya Yerlici 1 , Audrey Astori 2 , Nevraj S Kejiou 3 , Chris A Jordan 1 , Negin Khosraviani 1 , Janet N Y Chan 1 , Razqallah Hakem 4 , Brian Raught 5 , Alexander F Palazzo 3 , Karim Mekhail 6
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hinders host gene expression, curbing defenses and licensing viral protein synthesis and virulence. During SARS-CoV-2 infection, the virulence factor non-structural protein 1 (Nsp1) targets the mRNA entry channel of mature cytoplasmic ribosomes, limiting translation. We show that Nsp1 also restrains translation by targeting nucleolar ribosome biogenesis. SARS-CoV-2 infection disrupts 18S and 28S ribosomal RNA (rRNA) processing. Expression of Nsp1 recapitulates the processing defects. Nsp1 abrogates rRNA production without altering the expression of critical processing factors or nucleolar organization. Instead, Nsp1 localizes to the nucleolus, interacting with precursor-rRNA and hindering its maturation separately from the viral protein's role in restricting mature ribosomes. Thus, SARS-CoV-2 Nsp1 limits translation by targeting ribosome biogenesis and mature ribosomes. These findings revise our understanding of how SARS-CoV-2 Nsp1 controls human protein synthesis, suggesting that efforts to counter Nsp1's effect on translation should consider the protein's impact from ribosome manufacturing to mature ribosomes.
Keywords: CP: Microbiology; Molecular biology; RNA processing; SARS-CoV-2; non-structural protein 1 (Nsp1); nucleolus; ribosomal RNA (rRNA); ribosome biogenesis; translation.
. 2024 Feb 29;43(3):113891.
doi: 10.1016/j.celrep.2024.113891. Online ahead of print. SARS-CoV-2 targets ribosomal RNA biogenesis
V Talya Yerlici 1 , Audrey Astori 2 , Nevraj S Kejiou 3 , Chris A Jordan 1 , Negin Khosraviani 1 , Janet N Y Chan 1 , Razqallah Hakem 4 , Brian Raught 5 , Alexander F Palazzo 3 , Karim Mekhail 6
Affiliations
- PMID: 38427561
- DOI: 10.1016/j.celrep.2024.113891
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hinders host gene expression, curbing defenses and licensing viral protein synthesis and virulence. During SARS-CoV-2 infection, the virulence factor non-structural protein 1 (Nsp1) targets the mRNA entry channel of mature cytoplasmic ribosomes, limiting translation. We show that Nsp1 also restrains translation by targeting nucleolar ribosome biogenesis. SARS-CoV-2 infection disrupts 18S and 28S ribosomal RNA (rRNA) processing. Expression of Nsp1 recapitulates the processing defects. Nsp1 abrogates rRNA production without altering the expression of critical processing factors or nucleolar organization. Instead, Nsp1 localizes to the nucleolus, interacting with precursor-rRNA and hindering its maturation separately from the viral protein's role in restricting mature ribosomes. Thus, SARS-CoV-2 Nsp1 limits translation by targeting ribosome biogenesis and mature ribosomes. These findings revise our understanding of how SARS-CoV-2 Nsp1 controls human protein synthesis, suggesting that efforts to counter Nsp1's effect on translation should consider the protein's impact from ribosome manufacturing to mature ribosomes.
Keywords: CP: Microbiology; Molecular biology; RNA processing; SARS-CoV-2; non-structural protein 1 (Nsp1); nucleolus; ribosomal RNA (rRNA); ribosome biogenesis; translation.